These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 19663115)

  • 1. Tamoxifen-induced ultraviolet, recall dermatitis.
    Ledet JJ; Grafton LH
    J Drugs Dermatol; 2009 Aug; 8(8):761-2. PubMed ID: 19663115
    [No Abstract]   [Full Text] [Related]  

  • 2. Tamoxifen-induced radiation recall dermatitis.
    Kundranda MN; Daw HA
    Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
    [No Abstract]   [Full Text] [Related]  

  • 3. Tamoxifen induced radiation recall dermatitis in a breast cancer patient.
    Barco I; Fraile M; Vidal M; Cambra MJ; Vallejo E; Deu J; González S; Giménez N; Pessarrodona A; García-Fernández A
    Breast J; 2018 Jul; 24(4):662-663. PubMed ID: 29517150
    [No Abstract]   [Full Text] [Related]  

  • 4. Hormonal treatment duration in elderly patients: an open question.
    Crivellari D; Goldhirsch A; Coates A
    J Clin Oncol; 2004 Mar; 22(6):1164-5; author reply 1165. PubMed ID: 15020626
    [No Abstract]   [Full Text] [Related]  

  • 5. Tamoxifen-induced radiation recall dermatitis.
    Bourgeois A; Grisoli SB; Soine EJ; Rosen LB
    Dermatol Online J; 2017 Feb; 23(2):. PubMed ID: 28329490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tamoxifen-induced radiation recall dermatitis: three calls from Egypt.
    Salah E
    J Eur Acad Dermatol Venereol; 2017 Sep; 31(9):e386-e388. PubMed ID: 28231379
    [No Abstract]   [Full Text] [Related]  

  • 7. Does tamoxifen use affect prognosis in breast cancer patients who develop endometrial cancer?
    McCaul KA
    Obstet Gynecol; 2005 Jan; 105(1):217-8; author reply 218-9. PubMed ID: 15625169
    [No Abstract]   [Full Text] [Related]  

  • 8. A clinicopathologic study on patients with endometrial cancer after adjuvant tamoxifen treatment for breast cancer: a single center experience.
    Ravazoula P; Androutsopoulos G; Zyli P; Michail G; Kardamakis DM; Kourounis G
    Breast J; 2006; 12(6):578-84. PubMed ID: 17238994
    [No Abstract]   [Full Text] [Related]  

  • 9. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 10. [Radiotherapy-induced pemphigus].
    Correia MP; Santos D; Jorge M; Coutinho S
    Acta Med Port; 1998 Jun; 11(6):581-3. PubMed ID: 9773540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen.
    Nurs Times; 2006 Feb 21-27; 102(8):33. PubMed ID: 16519033
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen and pregnancy.
    Barthelmes L; Gateley CA
    Breast; 2004 Dec; 13(6):446-51. PubMed ID: 15563850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptance of tamoxifen chemoprevention by physicians and women at risk.
    McKay A; Latosinsky S; Martin W
    Cancer; 2005 Jan; 103(1):209-10. PubMed ID: 15540238
    [No Abstract]   [Full Text] [Related]  

  • 14. Tamoxifen-induced radiation recall dermatitis.
    Singer EA; Warren RD; Pennanen MF; Collins BT; Hayes DF
    Breast J; 2004; 10(2):170-1. PubMed ID: 15009054
    [No Abstract]   [Full Text] [Related]  

  • 15. What is the impact of tamoxifen on radiation-induced fibrosis in patients receiving breast-conserving therapy.
    Koc M
    J Clin Oncol; 2007 Dec; 25(36):5841; author reply 5844-5. PubMed ID: 18089889
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen-induced fatty liver in patients with breast cancer.
    Ogawa Y; Murata Y; Nishioka A; Inomata T; Yoshida S
    Lancet; 1998 Mar; 351(9104):725. PubMed ID: 9504521
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen or raloxifene for breast cancer chemoprevention: a tale of two choices--point.
    Jordan VC
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2207-9. PubMed ID: 18006908
    [No Abstract]   [Full Text] [Related]  

  • 18. Radiation-induced side effects with or without systemic therapies: prime time for prediction of individual radiosensitivity.
    Azria D; Rosenstein BS; Ozsahin M
    Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1293-4. PubMed ID: 18640495
    [No Abstract]   [Full Text] [Related]  

  • 19. Tamoxifen or raloxifene in postmenopausal women for prevention of breast cancer: a tale of two choices--counterpoint.
    Fabian C
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2210-2. PubMed ID: 18006909
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing perspective on breast cancer and chemotherapy. Three new developments are better able to predict breast cancer recurrence and chemotherapy effectiveness.
    Health News; 2006 Aug; 12(8):14-5. PubMed ID: 16913035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.